Phuong N. Huynh

Array ( [id] => 310913 [patent_doc_number] => 07527936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Modulators of angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/036643 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20774 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/527/07527936.pdf [firstpage_image] =>[orig_patent_app_number] => 11036643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 498052 [patent_doc_number] => 07208577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-24 [patent_title] => 'Methods of increasing lean tissue mass using OB protein compositions' [patent_app_type] => utility [patent_app_number] => 11/033600 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10420 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/208/07208577.pdf [firstpage_image] =>[orig_patent_app_number] => 11033600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766805 [patent_doc_number] => 20060018911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Design of therapeutics and therapeutics' [patent_app_type] => utility [patent_app_number] => 11/032773 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58325 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018911.pdf [firstpage_image] =>[orig_patent_app_number] => 11032773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5819977 [patent_doc_number] => 20060024290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Immunogenic LHRH compositions and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 11/027683 [patent_app_country] => US [patent_app_date] => 2005-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7155 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024290.pdf [firstpage_image] =>[orig_patent_app_number] => 11027683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050317 [patent_doc_number] => 20050186204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Use of antibodies against FLT-1 for the treatment of osteoporosis' [patent_app_type] => utility [patent_app_number] => 11/023278 [patent_app_country] => US [patent_app_date] => 2004-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5831 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186204.pdf [firstpage_image] =>[orig_patent_app_number] => 11023278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905151 [patent_doc_number] => 20050100546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Human monoclonal antibodies to epidermal growth factor receptor' [patent_app_type] => utility [patent_app_number] => 11/021795 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 37625 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100546.pdf [firstpage_image] =>[orig_patent_app_number] => 11021795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996273 [patent_doc_number] => 20050136051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Methods for generating multimeric molecules' [patent_app_type] => utility [patent_app_number] => 11/020084 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5568 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136051.pdf [firstpage_image] =>[orig_patent_app_number] => 11020084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038924 [patent_doc_number] => 20050158358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Tissue engineering scaffolds promoting matrix protein production' [patent_app_type] => utility [patent_app_number] => 11/018343 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4980 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158358.pdf [firstpage_image] =>[orig_patent_app_number] => 11018343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038923 [patent_doc_number] => 20050158357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Tissue engineering scaffolds promoting martix protein production' [patent_app_type] => utility [patent_app_number] => 11/018342 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4978 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158357.pdf [firstpage_image] =>[orig_patent_app_number] => 11018342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281486 [patent_doc_number] => 07553485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/012353 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 89 [patent_no_of_words] => 50353 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553485.pdf [firstpage_image] =>[orig_patent_app_number] => 11012353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957915 [patent_doc_number] => 20050214285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses' [patent_app_type] => utility [patent_app_number] => 11/005794 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 16413 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214285.pdf [firstpage_image] =>[orig_patent_app_number] => 11005794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250140 [patent_doc_number] => 20050142133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Optimized proteins that target the epidermal growth factor receptor' [patent_app_type] => utility [patent_app_number] => 11/004054 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 39869 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142133.pdf [firstpage_image] =>[orig_patent_app_number] => 11004054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 474887 [patent_doc_number] => 07226749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84' [patent_app_type] => utility [patent_app_number] => 10/998927 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5452 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 265 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226749.pdf [firstpage_image] =>[orig_patent_app_number] => 10998927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859015 [patent_doc_number] => 20080267865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Targeting of Erb Antigens' [patent_app_type] => utility [patent_app_number] => 10/596012 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12766 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267865.pdf [firstpage_image] =>[orig_patent_app_number] => 10596012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966024 [patent_doc_number] => 20050232921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => utility [patent_app_number] => 10/992195 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 121847 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232921.pdf [firstpage_image] =>[orig_patent_app_number] => 10992195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5015778 [patent_doc_number] => 20070258986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Targeted Delivery System for Bioactive Agents' [patent_app_type] => utility [patent_app_number] => 10/580108 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18386 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20070258986.pdf [firstpage_image] =>[orig_patent_app_number] => 10580108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599721 [patent_doc_number] => 07582726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'VEGF receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/985013 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10135 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582726.pdf [firstpage_image] =>[orig_patent_app_number] => 10985013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938499 [patent_doc_number] => 20050112062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Anti-idiotypic vascular endothelial growth factor antibodies and their use as medicaments' [patent_app_type] => utility [patent_app_number] => 10/978445 [patent_app_country] => US [patent_app_date] => 2004-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8095 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112062.pdf [firstpage_image] =>[orig_patent_app_number] => 10978445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100761 [patent_doc_number] => 20070184023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Method for down-regulation of vegf' [patent_app_type] => utility [patent_app_number] => 10/577489 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18378 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184023.pdf [firstpage_image] =>[orig_patent_app_number] => 10577489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776338 [patent_doc_number] => 20060104978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Methods and compositions for PDGF-C activation and inhibition' [patent_app_type] => utility [patent_app_number] => 10/971705 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15537 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104978.pdf [firstpage_image] =>[orig_patent_app_number] => 10971705 [rel_patent_id] =>[rel_patent_doc_number] =>)